A novel cocktail therapy based on quintuplet combination of oncolytic herpes simplex virus-2 vectors armed with interleukin-12, interleukin-15, GM-CSF, PD1v, and IL-7 × CCL19 results in enhanced antitumor efficacy

A novel cocktail therapy based on quintuplet combination of oncolytic herpes simplex virus-2 vectors armed with interleukin-12, interleukin-15, GM-CSF, PD1v, and IL-7 × CCL19 results in enhanced antitumor efficacy

Abstract Background Selectively replicating herpes simplex virus-2 (HSV-2) vector is a promising treatment for cancer therapy. The insertion of multiple transgenes into the viral genome has been performed to improve its oncolytic activity. Methods Herein, we simultaneously constructed five “armed” o...

Full description

Bibliographic Details
Main Authors: Han Hu, Siqi Zhang, Linkang Cai, Haixiao Duan, Yuying Li, Junhan Yang, Yang Wang, Biao Liu, Shuang Dong, Zhizheng Fang, Binlei Liu
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Virology Journal
Subjects:
Oncolytic herpes simplex virus
Combined therapy
4T1
CT26
Online Access:https://doi.org/10.1186/s12985-022-01795-1

Internet

https://doi.org/10.1186/s12985-022-01795-1

Similar Items